Screening microalgae for some potentially useful agricultural and pharmaceutical secondary metabolites

By V. Ördög, W. Stirk, R. Lenobel, M. Bancirova, Miroslav Strnad, J. van Staden, J. Szigeti, L. Nemeth. Journal of Applied Phycology, 2004

162 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Quality analysis of commercial Chlorella products used as dietary supplement in human nutrition (2010, background): “Extracts of C. vulgaris are considered to have antimicrobial effects (Pratt 1944, Ördög et al. 2004).”
Sustainability and cyanobacteria (blue-green algae): facts and challenges (2011, background): “In recent times, their ability to produce structurally novel and biologically active natural products has been recognised (Ordog et al. 2004; Gademan and Portman 2008; Sielaff et al. 2008; Wase and Wright 2008; Rosenberg et al. 2008; Tan 2010).”
Screening of microalgal culture media for the presence of algicidal compounds and isolation and identification of two bioactive metabolites, excreted by the cyanobacteria Nostoc insulare and Nodularia harveyana (2005, background): “…the past years with the aim to discover new antibiotic or cytotoxic metabolites of microalgae (green algae and cyanobacteria) (Falch et al., 1995; Ördög et al., 2004; Piccardi et al., 2000) as well as to discover cyanobacteria which were toxic to other cyanobacteria or green algae (Flores &…”
Microalgal Biotechnology: Prospects and Applications (2012, background): “Antibiotics are typically less effective against Gram- bacteria because of their complex, multilayered cell wall structure – which makes it more difficult for the active compound to penetrate them [69]; this justifies why the antibacterial activity of the supernatant (and methanolic extracts) is mor”